{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:08:21Z","timestamp":1791410901756,"version":"4.3.3"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2403,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Fulminant viral hepatitis (FH) remains an important clinical problem in which the underlying pathogenesis is not well understood. Here, we present insight into the immunological mechanisms involved in FH caused by murine hepatitis virus strain 3 (MHV-3), indicating a critical role for CD4\n                      <jats:sup>+<\/jats:sup>\n                      CD25\n                      <jats:sup>+<\/jats:sup>\n                      regulatory T cells (Tregs) and production of the novel Treg effector molecule FGL2. Before infection with MHV-3, susceptible BALB\/cJ mice had increased numbers of Tregs and expression of\n                      <jats:italic toggle=\"yes\">fgl2<\/jats:italic>\n                      messenger RNA (mRNA) and FGL2 protein compared with resistant A\/J mice. After MHV-3 infection, plasma levels of FGL2 in BALB\/cJ mice were significantly increased, correlating with increased percentage of Tregs. Treatment with anti-FGL2 antibody completely inhibited Treg activity and protected susceptible BALB\/cJ mice against MHV-3-liver injury and mortality. Adoptive transfer of wild-type Tregs into resistant\n                      <jats:italic toggle=\"yes\">fgl2<\/jats:italic>\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      mice increased their mortality caused by MHV-3 infection, whereas transfer of peritoneal exudate macrophages had no adverse effect.\n                      <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic>\n                      This study demonstrates that FGL2 is an important effector cytokine of Tregs that contributes to susceptibility to MHV-3\u2013induced FH. The results further suggest that targeting FGL2 may lead to the development of novel treatment approaches for acute viral hepatitis infection. (Hepatology 2009.)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.22684","type":"journal-article","created":{"date-parts":[[2008,10,14]],"date-time":"2008-10-14T17:55:27Z","timestamp":1224006927000},"page":"387-397","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":78,"title":["The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis #"],"prefix":"10.1097","volume":"49","author":[{"given":"Itay","family":"Shalev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit Man","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Maknojia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Zhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Fang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Selzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyedele","family":"Adeyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reginald R.","family":"Gorczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McGilvray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20260311","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3expressing CD25CD4 regulatory T cells in immunological tolerance to self and nonself.","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"key":"R2-11-20260311","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","article-title":"Natural regulatory T cells in infectious disease.","volume":"6","author":"Belkaid","year":"2005","journal-title":"Nat Immunol"},{"key":"R3-11-20260311","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/hep.20454","article-title":"An immunomodulatory role for CD4()CD25() regulatory T lymphocytes in hepatitis C virus infection.","volume":"40","author":"Cabrera","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R4-11-20260311","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","article-title":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.","volume":"41","author":"Stoop","year":"2005","journal-title":"HEPATOLOGY"},{"key":"R5-11-20260311","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","article-title":"Circulating and liver resident CD4CD25 regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.","volume":"177","author":"Xu","year":"2006","journal-title":"J Immunol"},{"key":"R6-11-20260311","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.3748\/wjg.v11.i24.3772","article-title":"Depletion of CD25CD4T cells (Tregs) enhances the HBVspecific CD8 T cell response primed by DNA immunization.","volume":"11","author":"Furuichi","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R7-11-20260311","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4049\/jimmunol.161.1.138","article-title":"Characterization of human fibroleukin, a fibrinogenlike protein secreted by T lymphocytes.","volume":"161","author":"Marazzi","year":"1998","journal-title":"J Immunol"},{"key":"R8-11-20260311","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0378-1119(95)00240-7","article-title":"Sequence of a human transcript expressed in Tlymphocytes and encoding a fibrinogenlike protein.","volume":"160","author":"Ruegg","year":"1995","journal-title":"Gene"},{"key":"R9-11-20260311","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20040179","article-title":"CD4CD25 T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.","volume":"199","author":"Herman","year":"2004","journal-title":"J Exp Med"},{"key":"R10-11-20260311","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3expressing regulatory T cells.","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol"},{"key":"R11-11-20260311","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ni1437","article-title":"Maintenance of the Foxp3dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.","volume":"8","author":"Williams","year":"2007","journal-title":"Nat Immunol"},{"key":"R12-11-20260311","doi-asserted-by":"crossref","first-page":"10382","DOI":"10.1128\/JVI.00747-06","article-title":"Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in AJ mice.","volume":"80","author":"De","year":"2006","journal-title":"J Virol"},{"key":"R13-11-20260311","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.176.3.689","article-title":"Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus infection (MHV3).","volume":"176","author":"Li","year":"1992","journal-title":"J Exp Med"},{"key":"R14-11-20260311","first-page":"1157","article-title":"Induction of resistant hepatocytes as a new principle for a possible shortterm in vivo test for carcinogens.","volume":"40","author":"Tsuda","year":"1980","journal-title":"Cancer Res"},{"key":"R15-11-20260311","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.4049\/jimmunol.174.11.7403","article-title":"Role of fibrinogenlike protein 2 prothrombinasefibroleukin in experimental and human allograft rejection.","volume":"174","author":"Ning","year":"2005","journal-title":"J Immunol"},{"key":"R16-11-20260311","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0021-9258(18)52364-4","article-title":"Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection.","volume":"266","author":"Fung","year":"1991","journal-title":"J Biol Chem"},{"key":"R17-11-20260311","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4049\/jimmunol.168.3.1069","article-title":"Regulatory T cells overexpress a subset of Th2 gene transcripts.","volume":"168","author":"Zelenika","year":"2002","journal-title":"J Immunol"},{"key":"R18-11-20260311","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1182\/blood-2003-09-3302","article-title":"Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25 regulatory thymocytes because of their responsiveness to different cytokines.","volume":"103","author":"Cosmi","year":"2004","journal-title":"Blood"},{"key":"R19-11-20260311","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.173.2.1224","article-title":"CD25CD4 cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development.","volume":"173","author":"McKee","year":"2004","journal-title":"J Immunol"},{"key":"R20-11-20260311","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1189\/jlb.0604341","article-title":"BALBc mice have more CD4CD25 T regulatory cells and show greater susceptibility to suppression of their CD4.","volume":"78","author":"Chen","year":"2005","journal-title":"J Leukoc Biol"},{"key":"R21-11-20260311","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.4049\/jimmunol.156.9.3342","article-title":"Resistance of naive mice to murine hepatitis virus strain 3 (MHV3) requires development of a TH1, but not TH2 response, whereas preexisting antibody protects against primary infection.","volume":"156","author":"Pope","year":"1996","journal-title":"J Immunol"},{"key":"R22-11-20260311","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.iy.13.040195.001055","article-title":"The regulation of immunity to Leishmania major.","volume":"13","author":"Reiner","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"R23-11-20260311","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1128\/jvi.69.9.5252-5260.1995","article-title":"Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.","volume":"69","author":"Pope","year":"1995","journal-title":"J Virol"},{"key":"R24-11-20260311","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","article-title":"Natural regulatory T cells: mechanisms of suppression.","volume":"13","author":"Miyara","year":"2007","journal-title":"Trends Mol Med"},{"key":"R25-11-20260311","doi-asserted-by":"crossref","first-page":"12287","DOI":"10.1073\/pnas.172382999","article-title":"Tumor necrosis factoralpha regulation of CD4CD25 T cell levels in NOD mice.","volume":"99","author":"Wu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26-11-20260311","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.84.6.1609","article-title":"Structure of a cytotoxic Tlymphocytespecific gene shows a strong homology to fibrinogen beta and gamma chains.","volume":"84","author":"Koyama","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-11-20260311","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.4049\/jimmunol.170.8.4036","article-title":"Soluble fibrinogenlike protein 2fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrowderived dendritic cells.","volume":"170","author":"Chan","year":"2003","journal-title":"J Immunol"},{"key":"R28-11-20260311","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4049\/jimmunol.180.1.249","article-title":"Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis.","volume":"180","author":"Shalev","year":"2008","journal-title":"J Immunol"},{"key":"R29-11-20260311","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/jmv.10290","article-title":"STAT1 and STAT3 alphabeta splice form activation predicts host responses in mouse hepatitis virus type 3 infection.","volume":"69","author":"Ning","year":"2003","journal-title":"J Med Virol"},{"key":"R30-11-20260311","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1172\/JCI18114","article-title":"The Fgl2fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.","volume":"112","author":"Marsden","year":"2003","journal-title":"J Clin Invest"},{"key":"R31-11-20260311","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1084\/jem.154.4.1150","article-title":"Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.","volume":"154","author":"Levy","year":"1981","journal-title":"J Exp Med"},{"key":"R32-11-20260311","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.4049\/jimmunol.176.11.7028","article-title":"Cytokineinduced hepatic apoptosis is dependent on FGL2fibroleukin: the role of Sp1Sp3 and STAT1PU.1 composite cis elements.","volume":"176","author":"Liu","year":"2006","journal-title":"J Immunol"},{"key":"R33-11-20260311","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1128\/jvi.69.8.5033-5038.1995","article-title":"Association of mouse fibrinogenlike protein with murine hepatitis virusinduced prothrombinase activity.","volume":"69","author":"Parr","year":"1995","journal-title":"J Virol"},{"key":"R34-11-20260311","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-0-387-33012-9_76","article-title":"Identification of the receptor for FGL2 and implications for susceptibility to mouse hepatitis virus (MHV3)induced fulminant hepatitis.","volume":"581","author":"Liu","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"R35-11-20260311","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1099\/0022-1317-72-6-1317","article-title":"Acquired immunity of AJ mice to mouse hepatitis virus 3 infection: dependence on interferongamma synthesis and macrophage sensitivity to interferongamma.","volume":"72","author":"Lucchiari","year":"1991","journal-title":"J Gen Virol"},{"key":"R36-11-20260311","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0171-2985(11)80089-6","article-title":"In vivo depletion of interferongamma leads to susceptibility of AJ mice to mouse hepatitis virus 3 infection.","volume":"185","author":"Lucchiari","year":"1992","journal-title":"Immunobiology"},{"key":"R37-11-20260311","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0002-9440(10)64992-9","article-title":"Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis.","volume":"156","author":"Levy","year":"2000","journal-title":"Am J Pathol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22684","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200902000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:02:03Z","timestamp":1773252123000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200902000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22684","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}